The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Asia Pacific cardiac holter monitor market is expected to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A cardiac holter monitor refers to a portable, battery-operated electrocardiography (ECG) device that records the patient’s heart rate for over 24 to 48 hours. It consists of a monitor, electrodes and software that help to assess the risk of future heart-related events in certain conditions, such as atrial fibrillation, tachycardia and arrhythmia. Nowadays, with the rising incidences of cardiac issues among individuals, these devices are widely being used across hospitals, clinics, and ambulatory surgical centers, as well as at homes for self-diagnosis.
The Asia Pacific cardiac holter monitor market is primarily driven by the increasing number of people diagnosed with heart-related diseases, such as cardiovascular diseases (CVDs), coronary artery disease (CAD), stroke and peripheral artery disease (PAD). This is due to hectic and long work schedules, sedentary lifestyles, and rising consumption of fast food across the region. Besides this, rapid modernization in the healthcare sector, coupled with the rising health concerns among individuals, has led to the adoption of cardiac holter monitors. The demand for these devices has also increased with the growing geriatric population, which is more susceptible to CVDs. As a result, manufacturers are introducing innovative and miniaturized diagnostic devices, which offer enhanced convenience. Furthermore, many companies are entering into partnerships for providing a comprehensive turnkey solution for general healthcare services. For instance, in April 2019, Koninklijke Philips N.V. entered into a seven-year partnership agreement with Hong Duc General Hospital in Ho Chi Minh City in Vietnam. Under the partnership, the company will provide the newly built Hong Duc General Hospital II with the latest patient monitoring, medical imaging and healthcare IT solutions.
IMARC Group provides an analysis of the key trends in each sub-segment of the Asia Pacific cardiac holter monitor market, along with forecasts at the regional and country level from 2021-2026. Our report has categorized the market based on product type, component and end user.
Breakup by Product Type:
Breakup by Component:
Breakup by End User:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Component, End User, Country|
|Countries Covered||China, Japan, India, South Korea, Australia, Indonesia, Others|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License $ 2499
Five User License $ 2999
Corporate License $ 3999
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at